RUFY1 Antibodies

Santa Cruz Biotechnology offers a broad range of RUFY1 monoclonal antibodies for research focused on understanding RUFY1 protein functions. RUFY1 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). RUFY1, or RUN and FYVE domain-containing protein 1, participates in cellular processes such as endocytosis and membrane trafficking. RUFY1 maintains a crucial presence in regulating the dynamics of cellular signaling pathways and cellular homeostasis. Research has shown that RUFY1 influences various diseases, including cancer and neurodegenerative disorders. Investigating RUFY1 functions continues to reveal new insights about its role in cellular processes. Understanding RUFY1's mechanisms can lead to breakthroughs in disease treatment and prevention. Exploring RUFY1's involvement in different biological pathways helps identify potential therapeutic targets. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of RUFY1 and its impact on human health.